Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of inhaled tobramycin solution in adults with bronchiectasis and pulmonary Pseudomonas aeruginosa infection
CTR20243571Phase 3Active
- Sponsor
- Hainan Sida Pharmaceutical
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tobramycin in bronchiectasis, Pseudomonas aeruginosa pulmonary infection, sponsored by Hainan Sida Pharmaceutical. Started Jan 2025; status: active.
02
Drugs
tobramycin
03
Conditions
bronchiectasisPseudomonas aeruginosa pulmonary infection
Beyond the preview
Go deeper on CTR20243571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243571.